Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients
Clinical trial NCT00162019 · COMPLETED
Trial details
- NCT number
- NCT00162019
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-31
- Primary completion
- 2004-08-24
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.